WELLINGTON, Fla., Nov. 10 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP), a Wellington, Florida based healthcare organization, announced today Quantum subsidiary Renaissance Health Systems of Florida, Inc. has expanded into three additional Florida Counties bringing the Company total to 29 counties. These counties geographically represent 86% of Florida's Medicare population.

Noel J. Guillama, President and CEO of The Quantum Group stated, "We are pleased by our continued expansion. Our presence in these three new counties was strategically planned to offer access to our provider system in the counties with the greatest number of Medicare eligible residents to our payor partners."

Barbara Roqueta, Senior Vice President of Operations for Renaissance Health Systems, commented, "The quality of our team responsible for developing these new counties, or as we call them community health systems (CHS), is first rate. The experience and dedication of this team is key to our success as they continue to build the quality and accessibility of our CHS."

The Company has projected expansion plans to the remaining counties in Florida and expects to announce further developments during Fiscal Year 2009 which began November 1, 2008.

About The Quantum Group, Inc.

The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.

Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation's largest and fastest growing industry.

We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

                    FOR MORE INFORMATION, PLEASE CONTACT:
                            PR Financial Marketing
                          Jim Blackman: 713-256-0369
                              jim@prfmonline.com
                                      or
                           The Quantum Group, Inc.
                        Danielle Amodio:  561.798.9800
                            damodio@quantummd.com

SOURCE The Quantum Group, Inc.